<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">pmj</journal-id><journal-title-group><journal-title xml:lang="ru">Тихоокеанский медицинский журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Pacific Medical Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1609-1175</issn><publisher><publisher-name>TGMU</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">pmj-986</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL RESEARCHES</subject></subj-group></article-categories><title-group><article-title>Анализ заболеваемости и результаты лечения ретинобластомы</article-title><trans-title-group xml:lang="en"><trans-title>Analysing morbidity and results of treatment of retinoblastoma</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бегимкулова</surname><given-names>А. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Begimkulova</surname><given-names>A. S.</given-names></name></name-alternatives><email xlink:type="simple">nco_kg@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Национальный центр онкологии Республики Кыргызстан</institution><country>Россия</country></aff><aff xml:lang="en"><institution>National Oncological Centre of the Kyrgyz Republic</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2011</year></pub-date><pub-date pub-type="epub"><day>28</day><month>09</month><year>2011</year></pub-date><volume>0</volume><issue>3</issue><fpage>39</fpage><lpage>41</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Бегимкулова А.С., 2011</copyright-statement><copyright-year>2011</copyright-year><copyright-holder xml:lang="ru">Бегимкулова А.С.</copyright-holder><copyright-holder xml:lang="en">Begimkulova A.S.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.tmj-vgmu.ru/jour/article/view/986">https://www.tmj-vgmu.ru/jour/article/view/986</self-uri><abstract><p>Проведен анализ уточненной заболеваемости ретинобластомой в Кыргызстане, изучена эффективность ее комплексного и комбинированного лечения за 1994-2008 гг. (78 случаев). Показано, что комбинированное лечение с использованием послеоперационной полихимиотерапии показывает лучшие результаты на I-IIIA стадиях опухоли (5-летняя выживаемость - 83 %). Подчеркивается, что улучшение выживаемости больных ретинобластомой зависит от своевременной диагностики и лечения на ранних стадиях заболевания в специализированных учреждениях.</p></abstract><trans-abstract xml:lang="en"><p>The paper analyses revised disease rate for retinoblastoma in the Kyrgyz Republic, studies efficiency of its integrated and combined treatment during 1994-2008 (78 cases) and summarises that the combined treatment using post-operative polychemotherapy appears to have better results at I-IIIA tumour stages (5-year survival rate is 83 %). The increasing survival rate of patients with retinoblastoma depends on timely diagnostics and early treatment in specialized medical departments.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>ретинобластома</kwd><kwd>дети</kwd><kwd>лечение</kwd><kwd>рецидив</kwd></kwd-group><kwd-group xml:lang="en"><kwd>retinoblastoma</kwd><kwd>children</kwd><kwd>treatment</kwd><kwd>recurrence</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Белкина Б.М., Голдобенко Г.В., Поляков В.Т. Совершенствование методов лечения двусторонних ретинобластом // Злокачественные опухоли головы и шеи: мат. симп. М., 1993. С. 50.</mixed-citation><mixed-citation xml:lang="en">Белкина Б.М., Голдобенко Г.В., Поляков В.Т. Совершенствование методов лечения двусторонних ретинобластом // Злокачественные опухоли головы и шеи: мат. симп. М., 1993. С. 50.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Бровкина А.Ф., Пантелеева О.Г. Результаты лечения ретинобластомы // Злокачественные опухоли головы и шеи: мат. симп. М., 1993. С. 49.</mixed-citation><mixed-citation xml:lang="en">Бровкина А.Ф., Пантелеева О.Г. Результаты лечения ретинобластомы // Злокачественные опухоли головы и шеи: мат. симп. М., 1993. С. 49.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Саакян С.В. Отдаленные результаты лечения детей с ретинобластомой при помощи неоадъювантной химиотерапии // Достижения и перспективы офтальмоонкологии: сб. тр. науч.-практ. конф. М., 2001. С. 156-158.</mixed-citation><mixed-citation xml:lang="en">Саакян С.В. Отдаленные результаты лечения детей с ретинобластомой при помощи неоадъювантной химиотерапии // Достижения и перспективы офтальмоонкологии: сб. тр. науч.-практ. конф. М., 2001. С. 156-158.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Eng C., Li EP., Abramson D.H. et al. Mortality from second tumors among long-term survivors of retinoblastoma // J. Natl. Cancer Inst. 1993. Vol. 85. P. 1121-1128.</mixed-citation><mixed-citation xml:lang="en">Eng C., Li EP., Abramson D.H. et al. Mortality from second tumors among long-term survivors of retinoblastoma // J. Natl. Cancer Inst. 1993. Vol. 85. P. 1121-1128.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Goddard A., Kingston J.E., Hungerford J.L. Delay in diagnosis of retinoblastoma, risk factors and treatment outcome // Br. J. Ophthalmol. 1999. Vol. 83. P. 1320-1323.</mixed-citation><mixed-citation xml:lang="en">Goddard A., Kingston J.E., Hungerford J.L. Delay in diagnosis of retinoblastoma, risk factors and treatment outcome // Br. J. Ophthalmol. 1999. Vol. 83. P. 1320-1323.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Heander C., Fu L.C., Pena A. et al. Impact of an education program on late diagnosis of retinoblastoma in Hondures // Pediatr. Blood Cancer. 2007. Vol. 46, No. 6. P. 817-819.</mixed-citation><mixed-citation xml:lang="en">Heander C., Fu L.C., Pena A. et al. Impact of an education program on late diagnosis of retinoblastoma in Hondures // Pediatr. Blood Cancer. 2007. Vol. 46, No. 6. P. 817-819.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Kingston J.E., Hungerford J.L. Retinoblastoma // Pediatric Oncology. Clinical Practice and Controversies / eds. P.N. Plowman, C.R. Pinkerton. London; New York; Tokyo: Chapman &amp; Hall Medical, 1992. P. 268-291.</mixed-citation><mixed-citation xml:lang="en">Kingston J.E., Hungerford J.L. Retinoblastoma // Pediatric Oncology. Clinical Practice and Controversies / eds. P.N. Plowman, C.R. Pinkerton. London; New York; Tokyo: Chapman &amp; Hall Medical, 1992. P. 268-291.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Nouvelles strategies de traitments conservateurs dans le retinoblastome. Project Curie 98. Curie Institute, France, 1998.</mixed-citation><mixed-citation xml:lang="en">Nouvelles strategies de traitments conservateurs dans le retinoblastome. Project Curie 98. Curie Institute, France, 1998.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Shields J.A., Shields C.L., De Potter P. Enucleation technique for children with retinoblastoma // J. Pediatr. Ophtalmol. Strabismus. 1992. Vol. 29. P. 213-215.</mixed-citation><mixed-citation xml:lang="en">Shields J.A., Shields C.L., De Potter P. Enucleation technique for children with retinoblastoma // J. Pediatr. Ophtalmol. Strabismus. 1992. Vol. 29. P. 213-215.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Woods W.G., Gao R.N., Shuster J.J. et al. Screening of infants and morrtality due to neuroblastoma // N. Engl. J. Med. 2002. Vol. 346. P. 1041-1046.</mixed-citation><mixed-citation xml:lang="en">Woods W.G., Gao R.N., Shuster J.J. et al. Screening of infants and morrtality due to neuroblastoma // N. Engl. J. Med. 2002. Vol. 346. P. 1041-1046.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
